Higher Rx Copays Affecting Pharmaceutical Sales Growth, IMS Exec Says
Executive Summary
The declining growth rate for pharmaceutical sales is partly due to rising patient copayments for prescriptions, IMS Health VP-Industry Relations Doug Long told the Pharmaceutical Care Management Association annual meeting in Bonita Springs, Fla. Oct. 28